Teva Pharmaceutical Industries (TEVA)
(Delayed Data from NYSE)
$16.63 USD
-0.35 (-2.06%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $16.65 +0.02 (0.12%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
Brokerage Reports
Teva Pharmaceutical Industries Ltd. [TEVA]
Reports for Purchase
Showing records 101 - 120 ( 457 total )
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Comprehensive Technical and Fundamental Analysis for TEVA.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Comprehensive Technical and Fundamental Analysis for TEVA.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Comprehensive Technical and Fundamental Analysis for TEVA.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Optimism on Near-Term Opioid Settlement Offsets Mediocre Q2
Provider: G.RESEARCH, LLC
Analyst: KEDRA K
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Comprehensive Technical and Fundamental Analysis for TEVA.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Comprehensive Technical and Fundamental Analysis for TEVA.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Comprehensive Technical and Fundamental Analysis for TEVA.
Provider: Stock Traders Daily
Analyst: Research Department